Streetbeat News

Revenues

POAI

Predictive Oncology Inc. (NASDAQ:POAI) collaborates with FluGen on developing an intranasal flu vaccine, funded by a $6.2M Phase 2B grant from the U.S. Department of Defense. The project aims to create a stable, soluble vaccine for global distribution, leveraging Predictive Oncology's biologics capabilities and AI-driven drug discovery expertise.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:44 pm

LMND

Lemonade has provided its Q2 revenue forecast, expecting it to be between $118M-$120M, which is below the estimated $123.02M. Additionally, the company anticipates its Gross Earned Premium for the same period to be between $197M-$199M.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:42 pm

AMZN

Amazon's CFO reported that 61% of the company's unit sales in Q1 came from third-party sellers, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:39 pm

AROC

Archrock's CEO, Brad Childers, announced an optimistic outlook for 2024, expecting to maintain high levels of utilization, pricing, and profitability. The company plans to raise the midpoint of its Adjusted EBITDA guidance for the full year, driven by strong oil prices, sustainable compression demand, and prudent capital discipline. Archrock's strong quarterly performance and strategic investments are supported by a favorable macro environment and the potential of natural gas in energy markets.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:36 pm

CCCS

CCC Intelligent Solutions projects Q2 revenue to be between $228.5M-$230.5M, slightly below the estimated $230.92M. For FY24, the company forecasts revenue to range from $944M-$950M, closely aligning with the $946.97M estimate.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:31 pm

CC

Chemours (NYSE:CC) reported Q1 sales of $1.350 billion, slightly beating the analyst consensus estimate of $1.349 billion by 0.04%. However, this represents a 12.11% decrease from the $1.536 billion sales reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:29 pm

KAI

Kadant Inc. has announced its financial guidance for FY24, maintaining its adjusted EPS in the range of $9.75 to $10.05, compared to the estimated $9.81. The company also forecasts revenue between $1.040 billion and $1.065 billion, slightly below the estimated $1.063 billion.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:28 pm

ESS

Essex Property Trust, Inc. (ESS) has revised its full-year 2024 guidance, projecting a Core FFO per diluted share of $15.03 to $15.43, which is below the $15.52 estimate. The company expects net income per diluted share to increase by $2.92 to a midpoint of $8.24, and forecasts growth in same-property revenues and NOI.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:23 pm

UDR

UDR, Inc. (NYSE:UDR) reported its Q1 2024 FFO As Adjusted per share at $0.61, meeting analyst consensus estimates. The company's rental income for the quarter was $411.669 million, surpassing the expected $409.645 million by 0.49% and marking a 3.35% increase from the previous year's $398.307 million.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:21 pm

INVH

Invitation Homes (NYSE:INVH) reported Q1 2024 Core FFO of $0.47 per share, surpassing the $0.46 estimate, with sales of $646.039M beating the $631.571M estimate, marking a 9.52% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:17 pm